ApprovalTrail

Approval · Notice of Compliance 12998 · 2012

MODAFINIL: Notice of Compliance 12998

Issued February 2, 2012

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
12998
Date
February 2, 2012
Company
AA Pharma Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
Manufacturer and product name change
Therapeutic class
Central Nervous System Stimulant
Canadian reference product
ALERTEC (Shire Biochem Inc.)

Products in this notice

BrandDINStatus today
MODAFINIL02285398Marketed

Medicinal ingredients